Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO)

Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO)

Abstract Background This study was conducted to investigate a new short-course radiotherapy regimen for patients with metastatic hormone refractory prostate cancer (HRPC) presenting with a dominant debilitating symptom. Methods / design This is an international, multi-center single arm prospective f...

Full description

Bibliographic Details
Main Authors: Jesper Carl, Dirk Rades, Claudia Doemer, Cornelia Setter, Jürgen Dunst, Niels Henrik Holländer
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Radiation Oncology
Subjects:
Prostate cancer
Metastatic disease
Dominant symptomatic lesion
High-precision radiotherapy
Hypo-fractionation
Feasibility
Online Access:http://link.springer.com/article/10.1186/s13014-019-1209-0

Internet

http://link.springer.com/article/10.1186/s13014-019-1209-0

Similar Items